Stoke Therapeutics, Inc. (STOK)
36.44
+2.15
(+6.27%)
USD |
NASDAQ |
Feb 23, 11:16
Stoke Therapeutics EPS Basic from Tax Loss Carryforward (Quarterly)
EPS Basic from Tax Loss Carryforward (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks
| Biogen, Inc. | -- |
| Insmed, Inc. | -- |
| Pfizer Inc. | -- |
| Mirum Pharmaceuticals, Inc. | -- |
| Moderna, Inc. | -- |